Lung and Breast Cancer Prevention by an Integrated Intervention of Maternal Smoking Cessation and Breastfeeding

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

October 30, 2023

Study Completion Date

October 30, 2023

Conditions
Smoking, CigaretteBreastfeeding
Interventions
BEHAVIORAL

Integrated intervention of smoking cessation and breastfeeding

The intervention group will receive an integrated intervention of smoking cessation and breastfeeding: education and counseling, monitoring and feedback, and contingent financial incentives.

BEHAVIORAL

Attention placebo control

Participants in the control group will receive usual prenatal care from physicians, nurses, or social workers. They will receive best standard care on smoking cessation and breastfeeding, including referral to the New York State Smokers' Quitline and the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC).

Trial Locations (1)

14214

Division of Behavioral Medicine Department of Pediatrics Jacobs School of Medicine and Biomedical Sciences State University of New York at Buffalo, Buffalo

All Listed Sponsors
collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

lead

Xiaozhong Wen

OTHER

NCT05123118 - Lung and Breast Cancer Prevention by an Integrated Intervention of Maternal Smoking Cessation and Breastfeeding | Biotech Hunter | Biotech Hunter